Society and Cultural News
March 8th, 2012 by admin
In a news release, Bedford Laboratories, in association with the US Food and Drug Administration (FDA), announced the voluntary recall of three lots of Cytarabine for Injection, USP, 1-gram per vial after a investigation of the place where the product was produced uncovered the possiblity for an increased risk for the lack of sterility.
Cytarabine, when combined with other FDA-approved anticancer medications, is used in remission induction in acute non-lymphocytic leukemia in both adults and children. The primary recall notification for the injections was sent to the potentially affected wholesalers and distributors in order to schedule the return of the affected product. Any wholesalers or distributors that potentially hold extra amounts of the injections should quarantine the products at once and call Bedford Laboratories to arrange their return. To date, no adverse health events have been reported in relation to this recall.
As a lancaster personal injury attorney, I’ve witnessed this sort of safety recall of a medical device before and know of the devastating injuries and illnesses that can come from the use of a defective item. If you’ve fallen ill due to the use of a defective medical device or product, it could be in your best interests to contact an experienced personal injury lawyer to discuss your legal rights as they apply to your situation.